The paper, written by four professors affiliated with Cambridge, Mass.-based Harvard University, outlines the potential problems associated with remote monitoring technology, including inadequate data protection and the fact that many of these tools are not considered medical devices and are thus not subject to FDA regulation.
“We want patients to know these technologies have been authorized for emergencies only on the limited criteria that they may be effective,” Sara Gerke, one of the paper’s authors, told STAT. “That doesn’t mean the products are safe and effective.”
The paper’s conclusion states that remote monitoring technology developers should be guided by the motto “ethics by design, even in a pandemic.”
More articles on telehealth:
Initiative will broaden 5G access nationwide, White House says
University Hospital, Rutgers launch 7-day virtual urgent care center
Atrium Health extends COVID-19 virtual hospital program to Navicent Health
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
